Minireview: regulation of steroidogenesis by electron transfer.
暂无分享,去创建一个
[1] W. Miller,et al. Regional mapping of genes encoding human steroidogenic enzymes: P450scc to 15q23-q24, adrenodoxin to 11q22; adrenodoxin reductase to 17q24-q25; and P450c17 to 10q24-q25. , 1991, DNA and cell biology.
[2] J. Tavaré,et al. Overexpression of protein kinase C isoenzymes alpha, beta I, gamma, and epsilon in cells overexpressing the insulin receptor. Effects on receptor phosphorylation and signaling. , 1993, The Journal of biological chemistry.
[3] T. Mohandas,et al. Assignment of the functional gene for human adrenodoxin to chromosome 11q13----qter and of adrenodoxin pseudogenes to chromosome 20cen----q13.1. , 1988, American journal of human genetics.
[4] J Deisenhofer,et al. Structure and function of cytochromes P450: a comparative analysis of three crystal structures. , 1995, Structure.
[5] I. Vakser,et al. Identification of the Binding Site on Cytochrome P450 2B4 for Cytochrome b 5 and Cytochrome P450 Reductase* , 1998, The Journal of Biological Chemistry.
[6] W. Miller. The molecular basis of premature adrenarche: an hypothesis , 1999, Acta paediatrica (Oslo, Norway : 1992). Supplement.
[7] V. Lingappa,et al. Rapid regulation of steroidogenesis by mitochondrial protein import , 2002, Nature.
[8] R. T. Miller,et al. The kinetic and spectral characterization of the E. coli-expressed mammalian CYP4A7: cytochrome b5 effects vary with substrate. , 2001, Archives of biochemistry and biophysics.
[9] S. Black,et al. Steroid 17 alpha-hydroxylase and 17,20-lyase activities of P450c17: contributions of serine106 and P450 reductase. , 1993, Endocrinology.
[10] R. Auchus,et al. Minireview: cellular redox state regulates hydroxysteroid dehydrogenase activity and intracellular hormone potency. , 2005, Endocrinology.
[11] W. Miller,et al. Molecular biology of mineralocorticoid metabolism. , 1996, Annual review of nutrition.
[12] O. Sibbesen,et al. Putidaredoxin Reductase-Putidaredoxin-Cytochrome P450cam Triple Fusion Protein , 1996, The Journal of Biological Chemistry.
[13] M. Forest. Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. , 2004, Human reproduction update.
[14] W. Miller,et al. Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[15] K. Tachibana,et al. Compound heterozygous mutations of cytochrome P450 oxidoreductase gene (POR) in two patients with Antley–Bixler syndrome , 2004, American journal of medical genetics. Part A.
[16] J. Peterson,et al. Association of cytochromes P450 with their reductases: opposite sign of the electrostatic interactions in P450BM-3 as compared with the microsomal 2B4 system. , 2000, Biochemistry.
[17] C. Corbin,et al. The Primate Adrenal Zona Reticularis is Defined by Expression of Cytochrome b5, 17α-hydroxylase/17,20-lyase Cytochrome P450 (P450c17) and NADPH-Cytochrome P450 Reductase (reductase) but not 3β-Hydroxysteroid Dehydrogenase/Δ5-4 Isomerase (3β-HSD) , 1999 .
[18] P. White,et al. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. , 2000, Endocrine reviews.
[19] R. Estabrook,et al. Evidence for the participation of cytochrome b 5 in hepatic microsomal mixed-function oxidation reactions. , 1971, Archives of biochemistry and biophysics.
[20] Israel Hanukoglu,et al. Stoichiometry of mitochondrial cytochromes P-450, adrenodoxin and adrenodoxin reductase in adrenal cortex and corpus luteum. Implications for membrane organization and gene regulation. , 1986, European journal of biochemistry.
[21] P. Hall,et al. Cytochrome b5 stimulates purified testicular microsomal cytochrome P-450 (C21 side-chain cleavage). , 1982, Biochemical and biophysical research communications.
[22] W. Miller,et al. Cytochrome b 5 Augments the 17,20-Lyase Activity of Human P450c17 without Direct Electron Transfer* , 1998, The Journal of Biological Chemistry.
[23] T. Poulos,et al. Structure of a cytochrome P450-redox partner electron-transfer complex. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[24] P. Hall,et al. Testicular microsomal cytochrome P-450 for C21 steroid side chain cleavage. Spectral and binding studies. , 1981, The Journal of biological chemistry.
[25] W. Miller,et al. Regulation of 17,20 Lyase Activity by Cytochrome b5 and by Serine Phosphorylation of P450c17* , 2005, Journal of Biological Chemistry.
[26] M. J. Coon,et al. Oxidation-reduction states of FMN and FAD in NADPH-cytochrome P-450 reductase during reduction by NADPH. , 1982, The Journal of biological chemistry.
[27] S. Gitelman,et al. Normal genes for the cholesterol side chain cleavage enzyme, P450scc, in congenital lipoid adrenal hyperplasia. , 1991, The Journal of clinical investigation.
[28] J. Omdahl,et al. Isolation and characterization of pig kidney mitochondrial ferredoxin:NADP+ oxidoreductase. , 1986, Journal of Biological Chemistry.
[29] J. Bahr,et al. Adrenocortical cytochrome b5 expression during fetal development of the rhesus macaque. , 2002, Endocrinology.
[30] Toshiaki Tanaka,et al. Compound heterozygous mutations in the cholesterol side-chain cleavage enzyme gene (CYP11A) cause congenital adrenal insufficiency in humans. , 2002, The Journal of clinical endocrinology and metabolism.
[31] Disorders of steroid 11β-hydroxylase isozymes , 1994 .
[32] W. Miller,et al. Cloning and sequence of the human adrenodoxin reductase gene. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[33] A. Steggles,et al. A splicing mutation in the cytochrome b5 gene from a patient with congenital methemoglobinemia and pseudohermaphrodism , 1994, Human Genetics.
[34] M. Waterman,et al. Expression of bovine 17 alpha-hydroxylase cytochrome P-450 cDNA in nonsteroidogenic (COS 1) cells. , 1986, Science.
[35] H. Sasano,et al. Immunohistochemical study of cytochrome b5 in human adrenal gland and in adrenocortical adenomas from patients with Cushing's syndrome. , 1998, Endocrine journal.
[36] K. Inouye,et al. Electrostatic interaction between cytochrome P450 and NADPH-P450 reductase: comparison of mixed and fused systems consisting of rat cytochrome P450 1A1 and yeast NADPH-P450 reductase. , 1999, Biochemical and biophysical research communications.
[37] W. Miller,et al. Vitamin D 1α-Hydroxylase , 2000, Trends in Endocrinology & Metabolism.
[38] V. Coghlan,et al. Expression of human ferredoxin and assembly of the [2Fe-2S] center in Escherichia coli. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[39] E. Jabs,et al. Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome , 2004, Nature Genetics.
[40] W. Freije,et al. Developmental changes in steroidogenic enzymes in human postnatal adrenal cortex: immunohistochemical studies , 2000, Clinical endocrinology.
[41] M. Suematsu,et al. Identification of Outer Mitochondrial Membrane Cytochrome b5 as a Modulator for Androgen Synthesis in Leydig Cells* , 2003, Journal of Biological Chemistry.
[42] S. Black,et al. cAMP post-transcriptionally diminishes the abundance of adrenodoxin reductase mRNA. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[43] A. Kaftory,et al. Congenital methemoglobinemia with a deficiency of cytochrome b5. , 1986, The New England journal of medicine.
[44] T. Aoyama,et al. Human NADPH-P450 oxidoreductase: complementary DNA cloning, sequence and vaccinia virus-mediated expression and localization of the CYPOR gene to chromosome 7. , 1989, Molecular pharmacology.
[45] R. Auchus,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society COMMENTARY Estrogen: Consequences and Implications of Human Mutations in Synthesis and Action* , 2022 .
[46] G. Schulz,et al. The structure of adrenodoxin reductase of mitochondrial P450 systems: electron transfer for steroid biosynthesis. , 1999, Journal of molecular biology.
[47] M. J. Coon,et al. Resolution of the cytochrome P-450-containing omega-hydroxylation system of liver microsomes into three components. , 1969, The Journal of biological chemistry.
[48] K. Suzuki,et al. Components of the electron transport system in adrenal steroid hydroxylase. Isolation and properties of non-heme iron protein (adrenodoxin). , 1967, The Journal of biological chemistry.
[49] A. Steggles,et al. The human liver and reticulocyte cytochrome b5 mRNAs are products from a single gene. , 1991, Biochemical and biophysical research communications.
[50] C. Kasper,et al. Association of Multiple Developmental Defects and Embryonic Lethality with Loss of Microsomal NADPH-Cytochrome P450 Oxidoreductase* , 2002, The Journal of Biological Chemistry.
[51] Y. Ito,et al. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. , 1994, Endocrine reviews.
[52] W. Miller. Why nobody has P450scc (20,22 desmoslase) deficiency. , 1998, The Journal of clinical endocrinology and metabolism.
[53] F. Guengerich,et al. Kinetics of ferric cytochrome P450 reduction by NADPH-cytochrome P450 reductase: rapid reduction in the absence of substrate and variations among cytochrome P450 systems. , 1997, Biochemistry.
[54] J. Toppari,et al. Near-miss apparent SIDS from adrenal crisis. , 2004, The Journal of pediatrics.
[55] W. Miller,et al. Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1. , 1997, Molecular endocrinology.
[56] W. Miller,et al. Molecular modeling of human P450c17 (17alpha-hydroxylase/17,20-lyase): insights into reaction mechanisms and effects of mutations. , 1999, Molecular endocrinology.
[57] S. Black,et al. The mitochondrial environment is required for activity of the cholesterol side-chain cleavage enzyme, cytochrome P450scc. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[58] A. Conley,et al. Colocalization of P450c17 and Cytochrome b5 in Androgen-Synthesizing Tissues of the Human1 , 2004, Biology of reproduction.
[59] H. Suzuki,et al. Purification and properties of cytochrome P-450 (SCC) from pig testis mitochondria. , 1991, Biochemical and biophysical research communications.
[60] W L Miller,et al. Molecular biology of steroid hormone synthesis. , 1988, Endocrine reviews.
[61] J. Sack,et al. Ambiguous genitalia due to partial activity of cytochromes P450c17 and P450c21 , 1992, The Journal of Steroid Biochemistry and Molecular Biology.
[62] J. Nakae,et al. Heterozygous mutation in the cholesterol side chain cleavage enzyme (p450scc) gene in a patient with 46,XY sex reversal and adrenal insufficiency. , 2001, The Journal of clinical endocrinology and metabolism.
[63] T. Ikenoue,et al. Charged Amino Acids at the Carboxyl-Terminal Portions Determine the Intracellular Locations of Two Isoforms of Cytochromeb 5 * , 1998, The Journal of Biological Chemistry.
[64] D. Ward,et al. The human cytochrome b5 gene and two of its pseudogenes are located on chromosomes 18q23, 14q31-32.1 and 20p11.2, respectively , 1993, Human Genetics.
[65] U. Heinemann,et al. New aspects of electron transfer revealed by the crystal structure of a truncated bovine adrenodoxin, Adx(4-108). , 1998, Structure.
[66] H. Yamazaki,et al. Reconstitution of recombinant cytochrome P450 2C10(2C9) and comparison with cytochrome P450 3A4 and other forms: effects of cytochrome P450-P450 and cytochrome P450-b5 interactions. , 1997, Archives of biochemistry and biophysics.
[67] R. E. Peterson,et al. Male pseudohermaphroditism due to multiple defects in steroid-biosynthetic microsomal mixed-function oxidases. A new variant of congenital adrenal hyperplasia. , 1985, The New England journal of medicine.
[68] C. Shackleton,et al. Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study , 2004, The Lancet.
[69] C. Kahn,et al. Phorbol ester-induced serine phosphorylation of the insulin receptor decreases its tyrosine kinase activity. , 1988, The Journal of biological chemistry.
[70] H. Yamazaki,et al. Lack of Electron Transfer from Cytochrome b5 in Stimulation of Catalytic Activities of Cytochrome P450 3A4 , 1996, The Journal of Biological Chemistry.
[71] R. Voutilainen,et al. Hormonal and developmental regulation of adrenodoxin messenger ribonucleic acid in steroidogenic tissues. , 1988, The Journal of clinical endocrinology and metabolism.
[72] J. Achermann,et al. Homozygous disruption of P450 side-chain cleavage (CYP11A1) is associated with prematurity, complete 46,XY sex reversal, and severe adrenal failure. , 2005, The Journal of clinical endocrinology and metabolism.
[73] W L Miller,et al. Cytochrome P450c17 (steroid 17 alpha-hydroxylase/17,20 lyase): cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[74] C. Jefcoate,et al. Adrenal mitochondrial cytochrome P-450scc. Cholesterol and adrenodoxin interactions at equilibrium and during turnover. , 1981, The Journal of biological chemistry.
[75] P. Hall,et al. C21 steroid side chain cleavage enzyme from porcine adrenal microsomes. Purification and characterization of the 17 alpha-hydroxylase/C17,20-lyase cytochrome P-450. , 1984, The Journal of biological chemistry.
[76] W L Miller,et al. Human cholesterol side-chain cleavage enzyme, P450scc: cDNA cloning, assignment of the gene to chromosome 15, and expression in the placenta. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[77] Yves Morel,et al. The molecular genetics of 21-hydroxylase deficiency. , 1989, Annual review of genetics.
[78] R. Voutilainen,et al. Human adrenodoxin: cloning of three cDNAs and cycloheximide enhancement in JEG-3 cells. , 1988, The Journal of biological chemistry.
[79] C. Wolf,et al. Inactivation of the Hepatic Cytochrome P450 System by Conditional Deletion of Hepatic Cytochrome P450 Reductase* , 2003, The Journal of Biological Chemistry.
[80] C. Kasper,et al. Role of Acidic Residues in the Interaction of NADPH-Cytochrome P450 Oxidoreductase with Cytochrome P450 and Cytochrome c(*) , 1995, The Journal of Biological Chemistry.
[81] V. Coghlan,et al. Electrostatic interactions stabilizing ferredoxin electron transfer complexes. Disruption by "conservative" mutations. , 1992, The Journal of biological chemistry.
[82] S. Kominami,et al. The role of cytochrome b 5 in adrenal microsomal steroidogenesis , 1992, The Journal of Steroid Biochemistry and Molecular Biology.
[83] W. Miller,et al. P450 oxidoreductase deficiency: a new disorder of steroidogenesis with multiple clinical manifestations , 2004, Trends in Endocrinology & Metabolism.
[84] L. Vickery,et al. Expression and characterization of human mitochondrial ferredoxin reductase in Escherichia coli. , 1992, Archives of biochemistry and biophysics.
[85] Joseph Sack,et al. Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis. , 2005, American journal of human genetics.
[86] P. Hall,et al. Microsomal cytochrome P-450 from neonatal pig testis. Purification and properties of A C21 steroid side-chain cleavage system (17 alpha-hydroxylase-C17,20 lyase). , 1981, The Journal of biological chemistry.
[87] T. Ogata,et al. Cytochrome P450 oxidoreductase gene mutations and Antley-Bixler syndrome with abnormal genitalia and/or impaired steroidogenesis: molecular and clinical studies in 10 patients. , 2005, The Journal of clinical endocrinology and metabolism.
[88] W. Miller,et al. Protein Phosphatase 2A and Phosphoprotein SET Regulate Androgen Production by P450c17* , 2003, The Journal of Biological Chemistry.
[89] K. Yanagibashi,et al. Role of electron transport in the regulation of the lyase activity of C21 side-chain cleavage P-450 from porcine adrenal and testicular microsomes. , 1986, The Journal of biological chemistry.
[90] W L Miller,et al. Cloning and structure of the human adrenodoxin gene. , 1988, DNA.
[91] N. Harada,et al. Core glycosylation of cytochrome P-450(arom). Evidence for localization of N terminus of microsomal cytochrome P-450 in the lumen. , 1993, The Journal of biological chemistry.
[92] C. Tickle,et al. Identification of Novel Roles of the Cytochrome P450 System in Early Embryogenesis: Effects on Vasculogenesis and Retinoic Acid Homeostasis , 2003, Molecular and Cellular Biology.
[93] D. Stocco,et al. Regulation of the acute production of steroids in steroidogenic cells. , 1996, Endocrine reviews.
[94] W. Miller,et al. The genetic and functional basis of isolated 17,20–lyase deficiency , 1997, Nature Genetics.
[95] C. W. Fisher,et al. The interaction of NADPH-P450 reductase with P450: an electrochemical study of the role of the flavin mononucleotide-binding domain. , 1996, Archives of biochemistry and biophysics.
[96] V. Coghlan,et al. Site-specific mutations in human ferredoxin that affect binding to ferredoxin reductase and cytochrome P450scc. , 1991, The Journal of biological chemistry.
[97] F. Dilworth,et al. Construction of a P450c27 fusion enzyme: a useful tool for analysis of vitamin D3 25-hydroxylase activity. , 1996, The Biochemical journal.
[98] T. Mohandas,et al. Human adrenodoxin reductase: two mRNAs encoded by a single gene on chromosome 17cen----q25 are expressed in steroidogenic tissues. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[99] M. Shet,et al. Construction of plasmids and expression in Escherichia coli of enzymatically active fusion proteins containing the heme-domain of a P450 linked to NADPH-P450 reductase. , 1996, Methods in enzymology.
[100] R. Bernhardt,et al. Construction and characterization of a catalytic fusion protein system: P-450(11beta)-adrenodoxin reductase-adrenodoxin. , 2000, Biochimica et biophysica acta.
[101] W. Miller,et al. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. , 1996, The New England journal of medicine.
[102] J. Lambeth,et al. Ionic effects on adrenal steroidogenic electron transport. The role of adrenodoxin as an electron shuttle. , 1979, The Journal of biological chemistry.
[103] S. Black,et al. Construction and function of fusion enzymes of the human cytochrome P450scc system. , 1993, DNA and cell biology.
[104] Israel Hanukoglu,et al. Induction and mitochondrial localization of cytochrome P450scc system enzymes in normal and transformed ovarian granulosa cells , 1990, The Journal of cell biology.
[105] B. Masters,et al. Three-dimensional structure of NADPH-cytochrome P450 reductase: prototype for FMN- and FAD-containing enzymes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[106] W. Miller,et al. P450c17 mutations R347H and R358Q selectively disrupt 17,20-lyase activity by disrupting interactions with P450 oxidoreductase and cytochrome b5. , 1999, Molecular endocrinology.
[107] P. Hall,et al. Microsomal cytochrome P-450 from neonatal pig testis: two enzymatic activities (17 alpha-hydroxylase and c17,20-lyase) associated with one protein. , 1981, Biochemistry.
[108] Jeffrey B. Cheng,et al. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[109] R. Estabrook,et al. Biochemical and genetic factors influencing drug metabolism. Influence of hepatic microsomal mixed function oxidation reactions on cellular metabolic control. , 1971, Metabolism: clinical and experimental.
[110] W. Miller,et al. The Regulation of Human P450c17 Activity: Relationship to Premature Adrenarche, Insulin Resistance and the Polycystic Ovary Syndrome , 1998, Trends in Endocrinology & Metabolism.
[111] W. Miller,et al. The regulation of 17,20 lyase activity , 1997, Steroids.